A031704-PD-INHIBITOR (NIVOLUMAB) AND IPILIMUMAB FOLLOWED BY NIVOLUMAB VS. VEGF TKI CABOZANTINIB WITH NIVOLUMAB: A PHASE III TRIAL IN METASTATIC UNTREATED RENAL CELL CANCER [PDIGREE]

https://clinicaltrials.gov/ct2/show/NCT03866382
Cancer - Kidney
Principal Investigator: Ding Wang, MD

Newly diagnosed renal cell cancer, renal cell cancer, kidney cancer, untreated advanced renal cell cancer, metastatic untreated renal cell cancer

Open